Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity

about

Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity

Item

http://www.wikidata.org/entity/Q37602843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Haplotype of platelet receptor ...... -treatment platelet reactivity

@en

Haplotype of platelet receptor ...... treatment platelet reactivity.

@nl

type

Item

label

Haplotype of platelet receptor ...... -treatment platelet reactivity

@en

Haplotype of platelet receptor ...... treatment platelet reactivity.

@nl

prefLabel

Haplotype of platelet receptor ...... -treatment platelet reactivity

@en

Haplotype of platelet receptor ...... treatment platelet reactivity.

@nl

P1476

Haplotype of platelet receptor ...... -treatment platelet reactivity

@en

P2093

Guang-Kai Liang

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jun-Lei Li

http://www.w3.org/2001/XMLSchema#string

Lu-Wen Shi

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Nie

http://www.w3.org/2001/XMLSchema#string

Xue-Li Yang

http://www.w3.org/2001/XMLSchema#string

Yang Xu

http://www.w3.org/2001/XMLSchema#string

Yong Zhang

http://www.w3.org/2001/XMLSchema#string

Yu Fu

http://www.w3.org/2001/XMLSchema#string

Yun Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO

Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

Genetic polymorphisms of platelet receptors in patients with acute myocardial infarction and resistance to antiplatelet therapy.

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

P2888

jzus.b1600333

P304

37-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1631/JZUS.B1600333

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020934612

http://www.w3.org/2001/XMLSchema#string

P698

28070995

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

5260476

http://www.w3.org/2001/XMLSchema#string